31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.
Clinical trial NCT03993171 · COMPLETED
Trial details
- NCT number
- NCT03993171
- Sponsor
- Clene Nanomedicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2025-05-27
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.